DSIP (Delta Sleep-Inducing Peptide)

What Delta Waves Are, and Why DSIP Is Named for Them

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-232 cited sources

Delta waves are high-amplitude EEG oscillations below roughly 4 Hz, dominant in the deepest stages of non-REM sleep. DSIP was named because the fraction isolated in 1977 increased delta activity in rabbit EEG — an electrophysiological measurement rather than a behavioural or subjective one.

Key facts

Frequency
Below approximately 4 Hz
Amplitude
High, relative to other EEG bands
Sleep stage
Deep non-REM (slow-wave sleep)
Measured by
Electroencephalography
Other bands
Theta, alpha, beta, gamma
Relevance to DSIP
The endpoint the 1977 name came from

What EEG frequency bands describe

An electroencephalogram records summed electrical activity from large populations of cortical neurons. That signal is conventionally divided into frequency bands — delta below about 4 Hz, then theta, alpha, beta and gamma at progressively higher frequencies. The bands are descriptive conventions rather than distinct biological entities, and which dominates reflects how synchronised the underlying population activity is.

Why delta means deep sleep

Slow, high-amplitude waves indicate that very large numbers of neurons are firing in near-synchrony. That degree of synchronisation is characteristic of deep non-REM sleep, when cortical activity is least driven by external input. Delta dominance is therefore the standard electrophysiological marker of slow-wave sleep, and it is what a sleep laboratory measures to stage sleep objectively.

Research material referenced

DSIP 5mg — third-party HPLC tested

View — £13.99

What the DSIP experiment actually measured

Delta activity in rabbit EEG. This is worth stating precisely because it is a narrower claim than 'induced sleep'. An EEG marker associated with deep sleep increased. Whether the animal was sleeping in the full sense, whether the effect was restorative, and whether the same would occur in another species are all separate questions the measurement does not answer.

Why an EEG endpoint is both strong and limited

It is strong because it is objective — instrument-recorded rather than reported, and not subject to expectation effects in an animal. It is limited because it is a correlate. Delta activity accompanies deep sleep, but producing delta activity is not the same as producing sleep, any more than raising a thermometer reading is the same as producing a fever.

Why the distinction matters for reading the literature

The name compresses a specific electrophysiological observation into a general functional claim, and that compression is where the confidence gets manufactured. Anyone reading DSIP's name as a summary of what it does is inheriting an inference the original measurement does not support on its own.

Extended research context

The DSIP (Delta Sleep-Inducing Peptide) deep dive

Deep dive: a name that was a hypothesis, not a finding

In 1977 the Schoenenberger-Monnier group in Basel electrically stimulated the thalamus of a sleeping rabbit, collected blood draining from its brain, isolated a peptide fraction, and reported that administering it into the ventricles of awake rabbits produced delta-wave EEG activity. They named it delta sleep-inducing peptide. By the standards of the time this was careful, imaginative work, and they followed it properly - the 1978 Pflugers Archiv paper reported sequence, synthesis and activity of the synthetic nonapeptide rather than stopping at a suggestive fraction. The problem is not the original research. It is that a name recording a hypothesis has been read ever since as a summary of established pharmacology, and almost nobody checks whether it was earned.

Deep dive: the three things that are missing

A proposed endogenous peptide becomes accepted biology by a recognisable route. The gene is located. The precursor protein is characterised. A receptor is identified, giving a mechanism and a testable target. DSIP has completed none of these in nearly fifty years. The receptor gap is the most disabling - without one there is no mechanism to test, no dose-response to build, no antagonist to design, and no way to establish that an observed effect runs through the proposed pathway at all. The gene gap is the hardest to explain away: modern genomics located MOTS-c inside a short open reading frame nested within the mitochondrial 12S rRNA gene, sequence already annotated as something else. That a peptide described in 1977 still has no identified gene in any genome is a substantive observation, not an accident of effort.

Deep dive: why 519 papers is not 519 confirmations

DSIP has roughly 519 indexed PubMed records - more than Selank's 135 or Semax's 231. Publication volume tracks how interesting a question is, not how well it has been answered. A tractable question generates a burst of work and then stops; a question that resists resolution generates papers indefinitely, each a further attempt rather than a further confirmation. Kovalzon's 2006 review in the Journal of Neurochemistry states the field's own assessment in its title: a still unresolved riddle. Reading any individual DSIP paper without that context invites mistaking activity for consensus.

Research applications

  • Historical study of humoral sleep-factor hypotheses
  • Electroencephalography and delta-wave research methodology
  • Structure-activity work on flexible, acidic short peptides
  • Comparative work on peptides lacking identified receptors
  • Analytical method development for tryptophan-containing peptides

Handling checklist

  • Store lyophilised material cold, dry and protected from light
  • No reducing agent needed — the sequence contains no cysteine
  • No methionine oxidation to expect; a +16 Da satellite warrants explanation
  • Protect from prolonged light — the single tryptophan is mildly photosensitive
  • Expect pH-dependent solubility; the peptide is strongly acidic with no basic residue
  • Aliquot to avoid repeated freeze-thaw cycles

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

Treating the name as evidence of the effect

Fix: The name records a 1977 hypothesis from a single rabbit EEG study. It is not a summary of established pharmacology.

Citing the 1977 paper as proof DSIP induces sleep

Fix: It reports delta-wave EEG activity in rabbits after intraventricular administration — a narrower claim than inducing sleep, in one species, by a route that bypasses every normal barrier.

Assuming DSIP is an established endogenous human peptide

Fix: No gene has been identified in any species, no precursor characterised and no receptor found.

Reading 519 papers as 519 confirmations

Fix: Volume reflects an unresolved question attracting sustained attempts, not accumulated confirmation.

Making any sleep claim about supplied material

Fix: The evidence does not support it and a therapeutic claim about research material is what MHRA enforcement targets.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Related questions researchers ask

  • What is DSIP?
  • Does DSIP actually induce sleep?
  • How was DSIP discovered?
  • Does DSIP have a receptor?
  • What are delta waves?
  • Is DSIP approved anywhere?

Frequently asked questions

Are delta waves the same as deep sleep?
They are the standard electrophysiological marker of it. Delta dominance accompanies deep non-REM sleep, but the marker and the state are not identical.
What did the 1977 DSIP study measure?
Delta-wave EEG activity in rabbits following intraventricular administration — an instrument-recorded electrophysiological endpoint.
Does producing delta activity mean producing sleep?
Not necessarily. Delta activity is a correlate of deep sleep, and increasing a correlate is a narrower result than producing the state.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

JM

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

More DSIP (Delta Sleep-Inducing Peptide) articles

Popular across the research hub

One flagship guide from every other research category — keep exploring.

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.